HR3916FEDERAL

High Impact

SCREENS for Cancer Act of 2024

June 11, 2025

healthcare cancer public health federal funding women's health

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

The bill authorizes $275 million in annual federal funding for fiscal years 2025 through 2029 to support breast and cervical cancer screening and diagnostic services for eligible populations.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

State health departments

State agencies receiving federal grants must align their programs with new requirements for patient navigation and evidence-based screening strategies.

High-risk populations

The program is explicitly tasked with reducing disparities in cancer incidence and mortality for these groups.

What changed

Last recorded activity June 11, 2025.

What's next

Introduced.

Summary

This bill reauthorizes and updates the National Breast and Cervical Cancer Early Detection Program through 2029. It expands the program's focus to include cancer prevention, services, and efforts to reduce health disparities, while authorizing $275 million in annual funding.

Key Facts

Authorizes $275 million in annual appropriations for the National Breast and Cervical Cancer Early Detection Program for fiscal years 2025 through 2029.
Expands program goals to include cancer prevention, not just detection and control.
Adds requirements for states to implement patient navigation and evidence-based strategies to increase screening rates.
Mandates that the program focus on reducing disparities in cancer incidence and mortality among high-risk populations.
Updates reporting requirements to Congress from an annual basis to a 5-year cycle.
Requires that screening and diagnostic services be provided based on national recommendations.
Removes specific subsections (d) from sections 1501 and 1503 of the Public Health Service Act.
Updates the committee name for reporting purposes to the Committee on Health, Education, Labor, and Pensions.

Frequently Asked Questions

What does this bill change about cancer screenings?

It shifts the program's focus to include prevention, adds services to help people access care, and mandates efforts to reduce health disparities.

How much money is being authorized?

$275 million per year for fiscal years 2025 through 2029.

How often will Congress receive reports on this program?

Under the new bill, reports will be submitted 2 years after enactment and every 5 years thereafter.

Why It Matters

The bill authorizes $275 million in annual federal funding for fiscal years 2025 through 2029 to support breast and cervical cancer screening and diagnostic services for eligible populations.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift100% confidence

Shift to Prevention

The bill explicitly expands the program's scope from 'detection and control' to 'prevention, detection, and control,' marking a broader public health approach.

Public Health Service Act

Connected Entities

personBrian Fitzpatrick“Co-sponsor of the bill.”Map →

personJoseph Morelle“Primary sponsor of the bill in the House of Representatives.”Map →

otherPublic Health Service Act“The existing law being amended by this bill.”Map →

Analysis Score

0–100

Significance75
How much this matters to a regular citizen
Controversy10
Intensity of disagreement among stakeholders
Entertainment5
Compellingness for a non-policy-wonk reader
Buzz20
Current news / social attention level

Publisher tools